Houston’s MD Anderson and Texas Children’s Advance New Hospital with $150M Kinder Foundation Gift
Date Published

A landmark collaboration between MD Anderson Cancer Center and Texas Children’s Hospital is set to reshape pediatric and young adult cancer care in Houston. The two institutions are moving ahead with plans for a new hospital supported by a $150 million donation from the Kinder Foundation, one of the largest philanthropic contributions to healthcare in the region.
The partnership, highlighted recently as a major development in Houston’s healthcare sector, will combine the expertise of two of the nation’s leading medical institutions. The yet-to-be-named facility will focus on providing advanced cancer treatment for children, adolescents, and young adults, expanding access to care for families across Texas and beyond.
What the New Hospital Will Offer
While full design details are still emerging, officials say the hospital will centralize pediatric oncology services and allow for expanded clinical programs. The collaboration aims to elevate treatment options, strengthen research opportunities, and accelerate new therapies.
Both MD Anderson and Texas Children’s Hospital bring long-standing expertise in oncology, but this joint facility is expected to streamline care and reduce barriers for young patients. The investment from the Kinder Foundation will support construction, program development, and long-term innovation.
Why It Matters for Houston
Houston has long been recognized as a global leader in medical research and clinical excellence. This new project further strengthens the city’s reputation and reinforces its role as a destination for world-class treatment. Families across the region could see shorter wait times, more clinical trial options, and improved continuity of care.
The Kinder Foundation’s donation also reflects ongoing philanthropic investment in Houston’s healthcare landscape. Significant gifts like this have helped sustain the Texas Medical Center’s growth and ensure that advances in patient care remain accessible to the community.
What’s Next
The project will continue through planning and development stages, with groundbreaking timelines expected at a later date. Officials say the partnership will remain a top priority for both institutions as they prepare to build a modern, patient-centered facility that expands the future of cancer treatment.
This article is a summary of reporting by The Business Journals. Read the full story here.
